TW201310B - - Google Patents

Download PDF

Info

Publication number
TW201310B
TW201310B TW080104597A TW80104597A TW201310B TW 201310 B TW201310 B TW 201310B TW 080104597 A TW080104597 A TW 080104597A TW 80104597 A TW80104597 A TW 80104597A TW 201310 B TW201310 B TW 201310B
Authority
TW
Taiwan
Prior art keywords
compound
patent application
acid
hydrogen
amine
Prior art date
Application number
TW080104597A
Other languages
English (en)
Chinese (zh)
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of TW201310B publication Critical patent/TW201310B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
TW080104597A 1990-06-29 1991-06-12 TW201310B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/546,622 US5194604A (en) 1990-06-29 1990-06-29 Process and intermediates for beta-lactams having aminothiazole(iminooxyacetic acid)acetic acid sidechains

Publications (1)

Publication Number Publication Date
TW201310B true TW201310B (en:Method) 1993-03-01

Family

ID=24181260

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080104597A TW201310B (en:Method) 1990-06-29 1991-06-12

Country Status (20)

Country Link
US (1) US5194604A (en:Method)
EP (1) EP0464705A1 (en:Method)
JP (1) JPH04261175A (en:Method)
KR (1) KR920000757A (en:Method)
CN (1) CN1029965C (en:Method)
AU (1) AU645810B2 (en:Method)
CA (1) CA2043817A1 (en:Method)
FI (1) FI913138L (en:Method)
HU (1) HU211083B (en:Method)
IE (1) IE912174A1 (en:Method)
IL (1) IL98395A0 (en:Method)
MX (1) MX26368A (en:Method)
MY (1) MY107234A (en:Method)
NO (1) NO912560L (en:Method)
NZ (1) NZ238631A (en:Method)
PL (1) PL165404B1 (en:Method)
PT (1) PT98139A (en:Method)
RU (1) RU2021270C1 (en:Method)
TW (1) TW201310B (en:Method)
ZA (1) ZA914348B (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045290A1 (en) * 1997-04-04 1998-10-15 Tokuyama Corporation 2-aminothiazoleacetamide derivatives
US7214364B2 (en) 2000-12-27 2007-05-08 Corus Pharma, Inc. Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
US6660249B2 (en) * 2000-12-27 2003-12-09 Salus Pharma, Inc. Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections
EP1527072A1 (en) 2002-08-05 2005-05-04 Teva Gyogyszergyar Reszvenytarsasag Preparation of aztreonam
WO2004103999A1 (en) * 2003-05-15 2004-12-02 TEVA Gyógyszergyár Részvénytársaság AZTREONAM β POLYMORPH WITH VERY LOW RESIDUAL SOLVENT CONTENT
WO2005005424A1 (en) * 2003-07-02 2005-01-20 TEVA Gyógyszergyár Részvénytársaság Aztreonam l-lysine and methods for the preparation thereof
US7601832B2 (en) * 2005-05-09 2009-10-13 Sicor, Inc. Process for making aztreonam
WO2015051101A1 (en) 2013-10-02 2015-04-09 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
CN103554054B (zh) * 2013-11-20 2015-03-25 山东金城医药化工股份有限公司 他啶侧链双酸的制备方法
CN104447610A (zh) * 2014-11-21 2015-03-25 山东金城医药化工股份有限公司 高纯度头孢他啶侧链酸的制备方法
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
AU2024447176A1 (en) * 2024-09-30 2026-04-16 Guangzhou HC New Drug Research Co., Ltd. β-LACTAM COMPOUND, AND CRYSTAL FORM, PREPARATION METHOD, AND USE THEREOF

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1299223A (en) * 1969-03-25 1972-12-13 Sankyo Co 6-aminopenicillanic acid compounds and novel cycloheptimidazolone compounds
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4775670A (en) * 1980-09-29 1988-10-04 E. R. Squibb & Sons, Inc. 2-oxo-1-azetidinesulfonic acid salts
US4533660A (en) * 1980-10-31 1985-08-06 E. R. Squibb & Sons, Inc. Antibacterial O-sulfated β-lactam hydroxamic acids
US4782147A (en) * 1980-12-05 1988-11-01 Takeda Chemical Industries, Ltd. 1-sulfo-2-oxoazetidine derivatives and their production
US4386034A (en) * 1981-02-02 1983-05-31 E. R. Squibb & Sons, Inc. Sulfamated amino acid amides
AU564150B2 (en) * 1982-04-30 1987-08-06 Takeda Chemical Industries Ltd. 1-sulfo-2-azetidinone derivatives
EP0097961B1 (en) * 1982-06-28 1987-11-11 Bristol-Myers Company Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives
US4500526A (en) * 1982-06-28 1985-02-19 Bristol-Myers Company Cephalosporin derivatives
JPS60112789A (ja) * 1983-11-21 1985-06-19 Otsuka Chem Co Ltd ３−アシルアミノ−４−アルキル−２−アゼチジノン−１−スルホン酸誘導体、その製造方法および該誘導体を含有する薬剤
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics

Also Published As

Publication number Publication date
FI913138A0 (fi) 1991-06-27
EP0464705A1 (en) 1992-01-08
AU7816391A (en) 1992-01-02
KR920000757A (ko) 1992-01-29
FI913138A7 (fi) 1991-12-30
AU645810B2 (en) 1994-01-27
HUT58090A (en) 1992-01-28
HU912202D0 (en) 1991-12-30
US5194604A (en) 1993-03-16
RU2021270C1 (ru) 1994-10-15
PL290856A1 (en) 1992-09-21
CN1029965C (zh) 1995-10-11
NO912560D0 (no) 1991-06-28
JPH04261175A (ja) 1992-09-17
MY107234A (en) 1995-10-31
NZ238631A (en) 1993-10-26
CA2043817A1 (en) 1991-12-30
PL165404B1 (pl) 1994-12-30
NO912560L (no) 1991-12-30
FI913138L (fi) 1991-12-30
HU211083B (en) 1995-10-30
PT98139A (pt) 1993-09-30
ZA914348B (en) 1992-03-25
CN1058593A (zh) 1992-02-12
IE912174A1 (en) 1992-01-01
MX26368A (es) 1994-02-28
IL98395A0 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
JP4536517B2 (ja) γ−セクレターゼ阻害剤としてのスルホンアミド、スルファメート及びスルファミド
WO2000012499A1 (en) Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
EP1611129A1 (en) Cyclic sulfamides for inhibition of gamma-secretase
US20070088063A1 (en) Gamma-secretase inhibitors
JP2006512301A5 (en:Method)
PT97214A (pt) Processo para a preparacao de acidos benzilfosfonicos inibidores da quinase da tirosina
JP2006502121A (ja) １Ｈ−イミダゾ［４，５−ｃ］キノリン−４−フタルイミド中間体を介する１Ｈ−イミダゾ−［４，５−ｃ］キノリン−４−アミンの調製
JP7408819B2 (ja) イソインドリン誘導体、並びにその医薬組成物及び使用
TW300221B (en:Method)
IE901665L (en) Arylthiazolylmethylimidazoles
WO2000021916A1 (fr) Procede de preparation de derives d'amine
JPH04261175A (ja) アミノチアゾール（イミノオキシ酢酸）置換アセチル側鎖を有するベータラクタムの製造法およびその中間体
TW480257B (en) Production of the intermediate 8-[2'(2(1)-tert-butyl-2H-tetrazol-5-yl)-biphenyl-4-yl-methyl]-2,4-dimethyl-5,8-dihydro-6H-pyrido[2,3-d] pyrimidin-7-one
EP1945604A1 (en) Process for the preparation of (omega-aminoalkylamino)alkyl halides and conversion to amifostine
TWI445711B (zh) 肝適能製備的改良方法
US7148222B2 (en) Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors
CN103087080B (zh) 一种盐酸头孢卡品酯的制备方法及其合成中间体
JPS596308B2 (ja) テトラゾ−ルチオ−ル誘導体
CN100516022C (zh) 高纯度烯胺类的制备方法
TW411341B (en) Process for preparation of 3-piperazinylbenzisothiazoles
US20070238877A1 (en) Novel Method for the Preparation of Aryl Piperazinyl-Heterocyclic Compounds
TW202328113A (zh) Shp2抑制劑、包含其的藥物組合物及其用途
JP3761206B2 (ja) １ｈ−ピラゾロ［３，２−ｃ］−１，２，４−トリアゾール系化合物の製造方法
WO2024249672A1 (en) Process of preparing hiv capsid inhibitor
JPS59134796A (ja) ６−アミノペニシラン酸のテトラアルキルアンモニウム塩を用いる６−アミノペニシラン酸エステルの製造法